Home › Type 2 Diabetes › Arizona
Type 2 Diabetes clinical trials in Arizona
21 studies for Type 2 Diabetes are looking for participants at sites in Arizona.
Cities in Arizona
- Tucson10 studies
- Phoenix9 studies
- Peoria5 studies
- Scottsdale4 studies
- Chandler4 studies
- Gilbert3 studies
- Mesa3 studies
A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
- Arizona Clinical Trials, Chandler
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 29, 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chandler Clinical Trials, Chandler
- Scottsdale Clinical Trials, Scottsdale
- Sun City Research, Sun City
- and 1 more
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Mission Research Institute - Gilbert, Gilbert
- Helios Clinical Research - Paradise Valley, Paradise Valley
- Arizona Liver Health - Peoria 85381, Peoria
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tempe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Arizona Clinical Trials - Pecos, Chandler
- Arizona Clinical Trials - Broadway, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
- Synexus Clinical Research US, Inc., Phoenix
- Pima Heart, Tucson
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Sun City
- Research Site, Surprise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Honor Health, Scottsdale
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Peoria
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07606066Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Desert Clinical Research, Mesa
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07527650A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of Arizona, Tucson
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
- Arizona Kidney Disease and Hypertension Center, Phoenix
- Innovative Diabetic Center, Scottsdale
Recruiting
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07187479DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Arizona State University, Phoenix
- Phoenix Children's, Phoenix
RecruitingObservational study
Ages 8 to 15 · All sexes · Updated May 7, 2026 · NCT06525259From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.